|
Asfotase alfa 107 mg/mL LIQUID
Lonza · NDC 67643-0017-03 · 936 mL in 1 BAG (67643-0017-3) |
67643-0017-03 |
— |
On market |
View → |
|
Burosumab 38.5 mg/mL LIQUID
Lonza · NDC 67643-0036-01 · 5000 mL in 1 BAG (67643-0036-1) |
67643-0036-01 |
— |
On market |
View → |
|
Efgartigimod Drug substance 215 mg/mL LIQUID
Lonza · NDC 67643-0031-01 · 4000 mL in 1 BOTTLE (67643-0031-1) |
67643-0031-01 |
— |
On market |
View → |
|
Eftrenonacog alfa 85 mg/mL LIQUID
Lonza · NDC 67643-0024-02 · 413 mL in 1 BOTTLE (67643-0024-2) |
67643-0024-02 |
— |
On market |
View → |
|
Fremanezumab 150 mg/mL LIQUID
Lonza · NDC 67643-0028-01 · 10000 mL in 1 BOTTLE (67643-0028-1) |
67643-0028-01 |
— |
On market |
View → |
|
Infliximab 40.0 mg/mL Drug Substance 40 mg/mL LIQUID
Lonza · NDC 67643-0012-01 · 1000 mL in 1 BOTTLE (67643-0012-1) |
67643-0012-01 |
— |
On market |
View → |
|
ISATUXIMAB 22 mg/mL LIQUID
Lonza · NDC 67643-0032-01 · 20000 mL in 1 BOTTLE (67643-0032-1) |
67643-0032-01 |
— |
On market |
View → |
|
LISOCABTAGENE MARALEUCEL LENTIVIRUS VECTOR 100000000 [iU]/mL SUSPENSION
Lonza · NDC 67643-5008-01 · 225 mL in 1 BOTTLE (67643-5008-1) |
67643-5008-01 |
— |
On market |
View → |
|
LISOCABTAGENE MARALEUCEL LENTIVIRUS VECTOR 100000000 [iU]/mL SUSPENSION
Lonza · NDC 67643-5008-01 · 225 mL in 1 BOTTLE (67643-5008-1) |
67643-5008-01 |
— |
On market |
View → |
|
MabY 158.5 mg/mL LIQUID
Lonza · NDC 67643-0033-01 · 16600 mL in 1 CONTAINER (67643-0033-1) |
67643-0033-01 |
— |
On market |
View → |
|
Mepolizumab Drug Substance 132 mg/mL LIQUID
Lonza · NDC 67643-0035-01 · 12000 mL in 1 BAG (67643-0035-1) |
67643-0035-01 |
— |
On market |
View → |
|
Obiltoxaximab 145 mg/mL LIQUID
Lonza · NDC 67643-0018-04 · 1900 mL in 1 BAG (67643-0018-4) |
67643-0018-04 |
— |
On market |
View → |
|
ocrelizumab 55 mg/mL LIQUID
Lonza · NDC 67643-7000-01 · 120000 mL in 1 TANK (67643-7000-1) |
67643-7000-01 |
— |
On market |
View → |
|
ocrelizumab 55 g/L LIQUID
Lonza · NDC 67643-7001-01 · 300 L in 1 TANK (67643-7001-1) |
67643-7001-01 |
— |
On market |
View → |
|
ocrelizumab 55 g/L LIQUID
Lonza · NDC 67643-7001-01 · 300 L in 1 TANK (67643-7001-1) |
67643-7001-01 |
— |
On market |
View → |
|
Ofatumumab 121 mg/mL LIQUID
Lonza · NDC 67643-0016-02 · 13500 mL in 1 BAG (67643-0016-2) |
67643-0016-02 |
— |
On market |
View → |
|
pertuzumab 33 mg/mL LIQUID
Lonza · NDC 67643-7003-01 · 300000 mL in 1 TANK (67643-7003-1) |
67643-7003-01 |
— |
On market |
View → |
|
pertuzumab 128 mg/mL LIQUID
Lonza · NDC 67643-7004-01 · 120000 mL in 1 TANK (67643-7004-1) |
67643-7004-01 |
— |
On market |
View → |
|
pertuzumab 33 mg/mL LIQUID
Lonza · NDC 67643-7002-01 · 120000 mL in 1 TANK (67643-7002-1) |
67643-7002-01 |
— |
On market |
View → |
|
rituximab 132 mg/mL LIQUID
Lonza · NDC 67643-7006-01 · 300000 mL in 1 TANK (67643-7006-1) |
67643-7006-01 |
— |
On market |
View → |
|
rituximab 60 mg/mL LIQUID
Lonza · NDC 67643-7005-01 · 120000 mL in 1 TANK (67643-7005-1) |
67643-7005-01 |
— |
On market |
View → |
|
Tafasitamab 42 mg/mL LIQUID
Lonza · NDC 67643-0029-01 · 16600 mL in 1 BAG (67643-0029-1) |
67643-0029-01 |
— |
On market |
View → |
|
tocilizumab 60 mg/mL LIQUID
Lonza · NDC 67643-7007-01 · 2000 mL in 1 BOTTLE (67643-7007-1) |
67643-7007-01 |
— |
On market |
View → |
|
Tocilizumab 198 mg/mL LIQUID
Lonza · NDC 67643-7008-01 · 2000 mL in 1 BOTTLE (67643-7008-1) |
67643-7008-01 |
— |
On market |
View → |
|
Vedolizumab IV 105 mg/mL LIQUID
Lonza · NDC 67643-0023-02 · 1800 mL in 1 BOTTLE (67643-0023-2) |
67643-0023-02 |
— |
On market |
View → |
|
Vedolizumab SC 176 mg/mL LIQUID
Lonza · NDC 67643-0034-01 · 2000 mL in 1 BOTTLE (67643-0034-1) |
67643-0034-01 |
— |
On market |
View → |